Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/19517
Title: B cells and antibody production in melanoma.
Authors: Da Gama Duarte, Jessica;Peyper, Janique M;Blackburn, Jonathan M
Affiliation: Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia
School of Cancer Medicine, La Trobe University, Melbourne, Australia
Department of Integrative Biomedical Sciences & Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
Issue Date: 3-Sep-2018
EDate: 2018-09-03
Citation: Mammalian genome : official journal of the International Mammalian Genome Society 2018; online first: 3 September
Abstract: Recent developments in the immuno-oncology field strongly support a role for the immune system in both the prevention and progression of melanoma. Melanoma is a highly immunogenic cancer, including its ability to induce tumour antigen-specific B cell and antibody responses through largely unknown mechanisms. This review considers likely hypothetical mechanisms by which anti-tumour surveillance detects pre-cancerous cells and by which immune (including B cell and antibody) responses may be elicited during malignancy. The review further considers potential pro- and anti-tumour functions of B cells and antibodies (including tertiary lymphoid structures) in both the tumour microenvironment and in circulation. Although the vast majority of studies have focused on T cells, recent evidence highlights the important roles of B cells in response to malignancy. B cells and antibodies are also discussed in the context of their potential utility as clinical biomarkers for various applications (as diagnostic, prognostic, therapeutic efficacy, and toxicity proxies), with a particular focus on protein microarray-based antibody detection and quantitation. Although the role of B cells in melanoma is incompletely understood, the measurement of circulating tumour-specific antibodies represents a promising avenue in the search for melanoma-relevant biomarkers.
URI: http://ahro.austin.org.au/austinjspui/handle/1/19517
DOI: 10.1007/s00335-018-9778-z
ORCID: 0000-0003-4289-5204
0000-0001-5992-2470
0000-0001-8988-9595
PubMed URL: 30178304
Type: Journal Article
Review
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.